Page 67 - Read Online
P. 67
Page 10 of 11 Narayanan et al. J Cancer Metastasis Treat 2019;5:36 I http://dx.doi.org/10.20517/2394-4722.2018.77
Consent for publication
Not applicable.
Copyright
© The Author(s) 2019.
REFERENCES
1. Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset
and mortality. Clin Colorectal Cancer 2016;15:195-203.
2. New Zealand Ministry of Health. Selected Cancers 2013, 2014 & 2015 (Provisional). Wellington: Ministry of Health; 2016.
3. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, et al. Guidelines for resection of colorectal cancer liver metastases. Gut
2006;55:iii1-8.
4. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011;6:479-507.
5. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon and Rectal Surg
2009;22:191-7.
6. Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of
1541 necropsies. J Pathol 1986;150:195-203.
7. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
8. Grillet F, Bayet E, Villeronce O, Zappia L, Lagerqvist EL, et al. Circulating tumour cells from patients with colorectal cancer have cancer
stem cell hallmarks in ex vivo culture. Gut 2017;66:1802-10.
9. Lahr CJ, Soong SJ, Cloud G, Smith JW, Urist MM, et al. A multifactorial analysis of prognostic factors in patients with liver metastases
from colorectal carcinoma. J Clin Oncol 1983;1:720-6.
10. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet
1994;343:1405-10.
11. Cady B, Stone MD. The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 1991;18:399-406.
12. Zalinski S, Mariette C, Farges O. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice
guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver
transplantation (ACHBT). Short version. J Visc Surg 2011;148:e171-82.
13. Shaheen, Mousa A, Hegazy NA, Nada OH, Radwan NA, et al. Immunohistochemical expression of stem cell markers CD133 and Oct4 in
colorectal adenocarcinoma. Egyptian Journal of Pathology 2014;34:44-51.
14. Baillie R, Itinteang T, Yu HH, Brasch HD, Davis PF, et al. Cancer stem cells in moderately differentiated oral tongue squamous cell
carcinoma. J of Clin Pathol 2016;69:742-4.
15. Yu HH, Featherston T, Tan ST, Chibnall AM, Brasch HD, et al. Characterization of cancer stem cells in moderately differentiated buccal
mucosal squamous cell carcinoma. Front Surg 2016;3:46.
16. Ram RS, Brasch HD, Dunne JC, Davis PF, Tan ST, et al. Cancer stem cells in moderately differentiated lip squamous cell carcinoma
express components of the renin-angiotensin system. Front Surg 2017;4:30.
17. Bradshaw AR, Wickremesekera AC, Brasch HD, Chibnall AM, Davis PF, et al. Glioblastoma multiforme cancer stem cells express
components of the renin-angiotensin system. Front Surg 2016;3:51.
18. Noto Z, Yoshida T, Okabe M, Koike C, Fathy M, et al. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer
stem-like cell characteristics. Oral Oncology;49:787-95.
19. Elsir T, Edqvist PH, Carlson J, Ribom D, Bergqvist M, et al. A study of embryonic stem cell-related proteins in human astrocytomas:
identification of nanog as a predictor of survival. Int J Cancer 2014;134:1123-31.
20. Chinn S, Darr O, Peters R, Prince M. The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis,
and treatment failure. Front Endocrinol (Lausanne) 2012;3:90.
21. Humphries H, Wickremesekera SK, Marsh RW, Brasch HD, Mehrotra S, et al. Characterisation of cancer stem cells in metastatic colon
adenocarcinoma to the liver. Front Surg 2018;4:76.
22. Munro MJ, Wickremesekera AC, Davis PF, Marsh R, Tan ST, et al. Renin-angiotensin system and cancer: a review. Integr Cancer Sci
Ther 2017; doi: 10.15761/ICST:1000231.
23. Nguyen G. Renin, (pro) renin and receptor: an update. Clin Sci (Lond) 2011;120:169-78.
24. Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008;29:1675-84.
25. Childers WK. Interactions of the renin-angiotensin system in colorectal cancer and metastasis. Int J Colorectal Dis 2015;30:749-52.
26. Heinzerling JH, Anthony T, Livingston EH, Huerta S. Predictors of distant metastasis and mortality in patients with stage II colorectal
cancer. Am Surg 2007;73:230-8.
27. Featherston T, Yu HH, Dunne JC, Chibnall AM, Brasch HD, et al. Cancer stem cells in moderately differentiated buccal mucosal
squamous cell carcinoma express components of the renin–angiotensin system. Front Surg 2016;3:52.
28. Itinteang T, Dunne JC, Chibnall AM, Brasch HD, Davis PF, et al. Cancer stem cells in moderately differentiated oral tongue squamous
cell carcinoma express components of the renin-angiotensin system. J Clin Pathol 2016;69:942-5.
29. Sun H, Li T, Zhuang R, Cai W, Zheng Y. Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in
cancer patients? Evidence from a meta-analysis including 55 studies. Medicine (Baltimore) 2017;96:e6394.
30. Tan EMS, Itinteang T, Chudakova DA, Dunne JC, Marsh R, et al. Characterisation of lymphocyte subpopulations in infantile